Kiran Dhillon
HER2 ICD vaccine trial findings featured on KIRO7 news
CVI's Executive Director Dr. Kiran Dhillon spoke with KIRO7 news anchors Monique Ming Laven and Gary Horcher about our recent publication...
top of page
Cancer Vaccine Institute News
Kiran Dhillon
Nov 21, 2022
KOMO4 News features CVI HER2 ICD DNA vaccine Phase I clinical trial
CVI Director Dr. Nora Disis spoke with Karina Vargas from KOMO4 news about the findings of our Phase I clinical trial with a HER2 ICD DNA...
Kiran Dhillon
Nov 21, 2022
HER2 ICD DNA vaccine study featured on Good Morning America & ABC News
We're excited to see the findings from our recent publication in JAMA Oncology describing our Phase I clinical trial with the HER2 ICD...
Kiran Dhillon
Oct 11, 2022
Dr. Disis featured in New York Times on the promise of cancer vaccines
Dr. Nora Disis (CVI Director) was featured in a New York Times article this week. Dr. Disis shares the promise of our STEMVAC vaccine for...
Kiran Dhillon
May 20, 2022
Cancer Vaccine Institute presents a summer educational series on immunology and cancer vaccines
The Cancer Vaccine Institute will hold a series of virtual seminars during June and July 2022. The five-part seminar series is an...
Blog: Blog2
bottom of page